Is it relevant to use an interleukin-1-inhibiting strategy for the treatment of patients with deficiency of interleukin-36 receptor antagonist?

被引：22
|
作者：
Tauber, M. [1 ,2 ]
Viguier, M. [2 ]
Le Gall, C. [1 ]
Smahi, A. [1 ]
Bachelez, H. [1 ,2 ]
机构：
[1] INSERM, Dept Genet, Imagine Inst, U781, F-75015 Paris, France
[2] Univ Paris Diderot, Hop St Louis, AP HP, Sorbonne Paris Cite,Dept Dermatol, Paris, France
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2014年 / 170卷 / 05期
关键词：
GENERALIZED PUSTULAR PSORIASIS; MUTATIONS; ANAKINRA; DISEASE;
D O I：
10.1111/bjd.12805
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：1198 / 1199
页数：2
相关论文
共 50 条
  • [41] Deficiency of Interleukin-1 Receptor Antagonist Responsive to Anakinra
    Schnellbacher, Charlotte
    Ciocca, Giovanna
    Menendez, Roxanna
    Aksentijevich, Ivona
    Goldbach-Mansky, Raphaela
    Duarte, Ana M.
    Rivas-Chacon, Rafael
    PEDIATRIC DERMATOLOGY, 2013, 30 (06) : 758 - 760
  • [42] An Autoinflammatory Disease with Deficiency of the Interleukin-1-Receptor Antagonist
    Aksentijevich, Ivona
    Masters, Seth L.
    Ferguson, Polly J.
    Dancey, Paul
    Frenkel, Joost
    van Royen-Kerkhoff, Annet
    Laxer, Ron
    Tedgard, Ulf
    Cowen, Edward W.
    Pham, Tuyet-Hang
    Booty, Matthew
    Estes, Jacob D.
    Sandler, Netanya G.
    Plass, Nicole
    Stone, Deborah L.
    Turner, Maria L.
    Hill, Suvimol
    Butman, John A.
    Schneider, Rayfel
    Babyn, Paul
    El-Shanti, Hatem I.
    Pope, Elena
    Barron, Karyl
    Bing, Xinyu
    Laurence, Arian
    Lee, Chyi-Chia R.
    Chapelle, Dawn
    Clarke, Gillian I.
    Ohson, Kamal
    Nicholson, Marc
    Gadina, Massimo
    Yang, Barbara
    Korman, Benjamin D.
    Gregersen, Peter K.
    van Hagen, P. Martin
    Hak, A. Elisabeth
    Huizing, Marjan
    Rahman, Proton
    Douek, Daniel C.
    Remmers, Elaine F.
    Kastner, Daniel L.
    Goldbach-Mansky, Raphaela
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (23): : 2426 - 2437
  • [43] Deficiency of Interleukin-36 Receptor Protected Cardiomyocytes from Ischemia-Reperfusion Injury in Cardiopulmonary Bypass
    Luo, Cheng
    Xie, Xiaoyong
    Feng, Xu
    Lei, Binfeng
    Fang, Chen
    Li, Yugui
    Cai, Xiongwei
    Ling, Guoxing
    Zheng, Baoshi
    MEDICAL SCIENCE MONITOR, 2020, 26
  • [44] The use of anakinra, an interleukin-1 receptor antagonist, in the treatment of rheumatoid arthritis
    Cohen, SB
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2004, 30 (02) : 365 - +
  • [45] Induction of interleukin 1 receptor antagonist after interleukin 1 therapy in patients with cancer
    Kopp, WC
    Urba, WJ
    Rager, HC
    Alvord, WG
    Oppenheim, JJ
    Smith, JW
    Longo, DL
    CLINICAL CANCER RESEARCH, 1996, 2 (03) : 501 - 506
  • [46] Treatment of rheumatoid arthritis with interleukin 1 receptor antagonist
    Bresnihan, B
    ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 : 96 - 98
  • [47] Safety and Efficacy of Rilonacept in Patients with Deficiency of Interleukin-1 Receptor Antagonist (DIRA)
    Neal, Dawn C. Chapelle
    de Jesus, Adriana Almeida
    Huang, Yan
    Liu, Yin
    Goldbach-Mansky, Raphaela
    Montealegre, Gina
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S996 - S996
  • [48] Amount of interleukin-1β and interleukin-1 receptor antagonist in periodontitis and healthy patients
    Gilowski, Lukasz
    Wiench, Rafal
    Plocica, Iwona
    Krzeminski, Tadeusz Faustyn
    ARCHIVES OF ORAL BIOLOGY, 2014, 59 (07) : 729 - 734
  • [49] The use of Anakinra (Interleukin-1 Receptor Antagonist) in the Treatment of Secondary Hemophagocytic Lymphohistiocytosis
    Bami, Sakshi
    Badawi, Mohamad
    Cannone, Daniel
    Cron, Randy
    Levy, Carolyn Fein
    PEDIATRIC BLOOD & CANCER, 2017, 64 : S32 - S32
  • [50] Interleukin-1 Receptor Antagonist treatment in Schnitzler syndrome
    Land, M.
    Riedl, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2008, 100 (01) : A68 - A68
12345